Not Yet Recruiting PHASE3 INTERVENTIONAL 3-arm NCT07274137

A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE）

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of MDR-001 Administered Orally Over 52 Weeks in Participants With Overweight or Obesity (MOBILE)

Sponsor: MindRank AI Ltd

Conditions Overweight or Obesity

Interventions MDR-001 Placebo

Updated 1 time since 2026 Last updated: Dec 15, 2025 Started: Feb 28, 2026 Primary completion: Jun 30, 2027 Completion: Jul 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Overweight or Obesity, this trial is actively recruiting participants. The trial is conducted by MindRank AI Ltd and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — PHASE3 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MindRank AI Ltd

Data source: MindRank AI Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Changchun, China , Changde, China , Changsha, China , Datong, China , Dongyang, China , Ganzhou, China , Hefei, China , Huizhou, China , Huzhou, China and 23 more locations